Literature DB >> 28328888

Better lab animal models for translational neuroscience research and CNS drug development.

Darya A Meshalkina1, Cai Song2, Allan V Kalueff2,3,4,5.   

Abstract

Mesh：

Year:  2017        PMID： 28328888     DOI： 10.1038/laban.1236

Source DB:  PubMed          Journal:  Lab Anim (NY)        ISSN： 0093-7355            Impact factor:   12.625


× No keyword cloud information.
  10 in total

1.  Preclinical research: Make mouse studies work.

Authors:  Steve Perrin
Journal:  Nature       Date:  2014-03-27       Impact factor: 49.962

Review 2.  Zebrafish as an emerging model for studying complex brain disorders.

Authors:  Allan V Kalueff; Adam Michael Stewart; Robert Gerlai
Journal:  Trends Pharmacol Sci       Date:  2014-01-09       Impact factor: 14.819

Review 3.  A Critical Review of Repurposing Apomorphine for Smoking Cessation.

Authors:  Joel A Morales-Rosado; Margot A Cousin; Jon O Ebbert; Eric W Klee
Journal:  Assay Drug Dev Technol       Date:  2015-12       Impact factor: 1.738

4.  Multipotent stromal cells alleviate inflammation, neuropathology, and symptoms associated with globoid cell leukodystrophy in the twitcher mouse.

Authors:  Brittni A Scruggs; Xiujuan Zhang; Annie C Bowles; Peter A Gold; Julie A Semon; Jeanne M Fisher-Perkins; Shijia Zhang; Ryan W Bonvillain; Leann Myers; Su Chen Li; Allan V Kalueff; Bruce A Bunnell
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

Review 5.  Zebrafish models for translational neuroscience research: from tank to bedside.

Authors:  Adam Michael Stewart; Oliver Braubach; Jan Spitsbergen; Robert Gerlai; Allan V Kalueff
Journal:  Trends Neurosci       Date:  2014-04-09       Impact factor: 13.837

Review 6.  Neurobiology of rodent self-grooming and its value for translational neuroscience.

Authors:  Allan V Kalueff; Adam Michael Stewart; Cai Song; Kent C Berridge; Ann M Graybiel; John C Fentress
Journal:  Nat Rev Neurosci       Date:  2015-12-17       Impact factor: 34.870

Review 7.  Zebrafish models of human motor neuron diseases: advantages and limitations.

Authors:  Patrick J Babin; Cyril Goizet; Demetrio Raldúa
Journal:  Prog Neurobiol       Date:  2014-04-03       Impact factor: 11.685

8.  High-throughput screening of stem cell therapy for globoid cell leukodystrophy using automated neurophenotyping of twitcher mice.

Authors:  Brittni A Scruggs; Annie C Bowles; Xiujuan Zhang; Julie A Semon; Evan J Kyzar; Leann Myers; Allan V Kalueff; Bruce A Bunnell
Journal:  Behav Brain Res       Date:  2012-08-20       Impact factor: 3.332

9.  Larval zebrafish model for FDA-approved drug repositioning for tobacco dependence treatment.

Authors:  Margot A Cousin; Jon O Ebbert; Amanda R Wiinamaki; Mark D Urban; David P Argue; Stephen C Ekker; Eric W Klee
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

10.  A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo therapeutic screening.

Authors:  Marc M J Da Costa; Claire E Allen; Adrian Higginbottom; Tennore Ramesh; Pamela J Shaw; Christopher J McDermott
Journal:  Dis Model Mech       Date:  2013-10-02       Impact factor: 5.758
  10 in total
  3 in total

Review 1.  Advancements in Genomic and Behavioral Neuroscience Analysis for the Study of Normal and Pathological Brain Function.

Authors:  Annalisa M Baratta; Adam J Brandner; Sonja L Plasil; Rachel C Rice; Sean P Farris
Journal:  Front Mol Neurosci       Date:  2022-06-23       Impact factor: 6.261

2.  Adult zebrafish in CNS disease modeling: a tank that's half-full, not half-empty, and still filling.

Authors:  Darya A Meshalkina; Elana V Kysil; Jason E Warnick; Konstantin A Demin; Allan V Kalueff
Journal:  Lab Anim (NY)       Date:  2017-10-06       Impact factor: 12.625

3.  Embelin Prevents Seizure and Associated Cognitive Impairments in a Pentylenetetrazole-Induced Kindling Zebrafish Model.

Authors:  Uday Praful Kundap; Yam Nath Paudel; Yatinesh Kumari; Iekshan Othman; Mohd Farooq Shaikh
Journal:  Front Pharmacol       Date:  2019-04-17       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.